NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ascend Advanced Therapies

Ascend Advanced Therapies

Private
LondonHealthcare & Life Scienceshttps://www.ascend-adv.com/

Last Round

Strategic

Nov 12, 2024

Total Funding Raised

$263.5M

Company Overview

Ascend Advanced Therapies is a biotechnology company that provides contract development and manufacturing services for gene and cell therapy developers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

CDMOgene therapy manufacturingcell therapy manufacturingviral vector manufacturingadvanced therapy medicinal productsATMPbiotech manufacturingprocess developmentanalytical developmentfill and finishCMC servicesGMP manufacturingbioprocessingclinical stage manufacturingbiotech outsourcing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ascend Advanced Therapies Comparables

Compare Ascend Advanced Therapies with similar companies based on industry and business-model similarity.

Ascend Advanced Therapies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Andelyn Biosciences
90%
Advanced Medicine Partners
84%
Ajinomoto Co. Inc
81%

Ascend Advanced Therapies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicNov 12, 2024
Series AMar 20, 2023
SeedJun 22, 2021

Key People

Founding team and executive leadership

Alessandra Rispoli

CEO

Executive Team

Mike Stella

Chief Executive Officer and Director

Executive Team

Sharad Dubey

Chief Financial Officer

Executive Team

Wes McConnell

Chief Financial Officer

Executive Team

Ascend Advanced Therapies Investors

Notable investors and investment history

Ascend Advanced Therapies investors
InvestorRounds
Cathay CapitalSeries A, Strategic
Deerfield ManagementSeries A, Strategic
EW Healthcare PartnersStrategic
Digitalis VenturesSeries A, Strategic
DCVC BioSeries A, Strategic
4BIO CapitalSeries A, Strategic
Ajinomoto Co., Inc.Series A

Ascend Advanced Therapies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ascend Advanced Therapies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ascend Advanced Therapies's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range103
Year Founded2021
Last FundingNov 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.